Ajinomoto Co., Inc. (TYO:2802)
Japan · Delayed Price · Currency is JPY 3,968.00
+36.00 (0.92%)
Aug 13, 2025, 9:44 AM JST
Singular Genomics Systems Revenue
Ajinomoto Co. had revenue of 364.01B JPY in the quarter ending June 30, 2025, a decrease of -0.41%. This brings the company's revenue in the last twelve months to 1.53T, up 4.36% year-over-year. In the fiscal year ending March 31, 2025, Ajinomoto Co. had annual revenue of 1.53T with 6.35% growth.
Revenue (ttm)
1,529.06B
Revenue Growth
+4.36%
P/S Ratio
2.51
Revenue / Employee
43.86M
Employees
34,860
Market Cap
3,840.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,530.56B | 91.33B | 6.35% |
| Mar 31, 2024 | 1,439.23B | 80.12B | 5.89% |
| Mar 31, 2023 | 1,359.12B | 209.75B | 18.25% |
| Mar 31, 2022 | 1,149.37B | 77.92B | 7.27% |
| Mar 31, 2021 | 1,071.45B | -28.59B | -2.60% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Japan Tobacco | 3,314.41B |
| Seven & i Holdings | 10.37T |
| Pan Pacific International Holdings | 2,215.91B |
| Kao Corporation | 1,649.48B |
| Asahi Group Holdings | 2,920.01B |
| Unicharm | 965.42B |
| Kirin Holdings Company | 2,378.87B |
| Suntory Beverage & Food | 1,685.82B |
Ajinomoto Co. News
- 8 days ago - Ajinomoto Co., Inc. 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 8 days ago - Ajinomoto Co., Inc. (AJINY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ajinomoto GAAP EPS of ¥32.62, revenue of ¥364.01B; reaffirms FY outlook - Seeking Alpha
- 3 months ago - Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ajinomoto Co GAAP EPS of ¥69.77 - Seeking Alpha
- 3 months ago - Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges - Business Wire
- 3 months ago - L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co. - GlobeNewsWire
- 3 months ago - L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik - GlobeNewsWire